“The whole is greater than the sum of its parts” is a maxim attributed to the prolific ancient Greek philosopher and scientist Aristotle.
At QBRI, we believe that far more can be accomplished through collaboration and continually pursue partnerships with national, regional and international institutions of the highest caliber.
The whole is indeed far greater than the sum of its parts. Together with our partners from leading American and European biomedical institutions, as well as stakeholders in Qatar and the region, the impact that we are collectively making extends far beyond the borders of Qatar.
We do not believe in limitations; we believe in possibilities. As a global hub for biomedical and translational research, QBRI has transcended geographical borders. Our team is driven by our desire to make valuable contributions to the biomedical field and revolutionize healthcare in Qatar and across the globe.
QBRI has successfully established and actively seeks collaborations and strategic partnerships with distinguished scientists and research institutions to support the development of its program and build scientific capacity, while engaging in groundbreaking research at the crossroads of biology, medicine, biomarkers, translational medicine and personalized healthcare. Among our partners and collaborators are Hamad Medical Corporation (HMC), the Shafallah Center, Sidra Medicine, Qatar University, Weill Cornell Medicine - Qatar, Anti-Doping Lab Qatar, the King Hussein Cancer Center, the Harvard Stem Cell Institute, Cleveland Clinic, AFFiRis, Olink, Lundbeck and Sengenics.